Literature DB >> 11448232

ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.

F Lombardo1, M Y Shalaeva, K A Tupper, F Gao.   

Abstract

We present an RP-HPLC method for the determination of the octanol-water distribution coefficients at pH 7.4, as log values, for neutral and basic drugs, which combines ease of operation with high accuracy. The method is shown to work for a training set of 90 molecules comprised largely of drugs, and it was also applied to a test set of 10 proprietary compounds. This work expands the applicability of the method presented in our earlier report, for the determination of logP(oct) for neutral compounds (J. Med. Chem. 2000, 43, 2922-2928), and it offers the same general features but widens the scope. Generally, the method (i) is compound sparing (< or =1 mL of a 50-100 microg/mL solution needed), (ii) is insensitive to concentration and phase ratio effects observed in some shake-flask determinations, (iii) is amenable to rapid determinations (< or = 20 min on average), (iv) is insensitive to impurities, (v) possesses a wide lipophilicity range (>7 log units), and (vi) offers a good accuracy, (vii) an excellent reproducibility, (viii) and an excellent potential for automation. To the best of our knowledge, a similar performance, on a set of noncongeneric drugs, has not been previously reported. We refer to the value generated via this method as ElogD(oct).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11448232     DOI: 10.1021/jm0100990

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  36 in total

1.  Effect of liposomes on energy-dependent uptake of the antioxidant SkQR1 by isolated mitochondria.

Authors:  Yuri N Antonenko; Irina V Perevoshchikova; Tatyana I Rokitskaya; Ruben A Simonyan; Vadim V Tashlitsky; Vladimir P Skulachev
Journal:  J Bioenerg Biomembr       Date:  2012-06-22       Impact factor: 2.945

2.  Progress in antischistosomal N,N'-diaryl urea SAR.

Authors:  Jianbo Wu; Chunkai Wang; Derek Leas; Mireille Vargas; Karen L White; David M Shackleford; Gong Chen; Austin G Sanford; Ryan M Hemsley; Paul H Davis; Yuxiang Dong; Susan A Charman; Jennifer Keiser; Jonathan L Vennerstrom
Journal:  Bioorg Med Chem Lett       Date:  2017-12-29       Impact factor: 2.823

3.  Trypanothione reductase high-throughput screening campaign identifies novel classes of inhibitors with antiparasitic activity.

Authors:  Georgina A Holloway; William N Charman; Alan H Fairlamb; Reto Brun; Marcel Kaiser; Edmund Kostewicz; Patrizia M Novello; John P Parisot; John Richardson; Ian P Street; Keith G Watson; Jonathan B Baell
Journal:  Antimicrob Agents Chemother       Date:  2009-04-13       Impact factor: 5.191

4.  Novel Toxoplasma gondii inhibitor chemotypes.

Authors:  A G Sanford; T T Schulze; L P Potluri; R M Hemsley; J J Larson; A K Judge; S J Zach; X Wang; S A Charman; J L Vennerstrom; P H Davis
Journal:  Parasitol Int       Date:  2018-01-04       Impact factor: 2.230

5.  Novel mitochondria-targeted antioxidants: plastoquinone conjugated with cationic plant alkaloids berberine and palmatine.

Authors:  Konstantin G Lyamzaev; Antonina V Pustovidko; Ruben A Simonyan; Tatyana I Rokitskaya; Lidia V Domnina; Olga Yu Ivanova; Inna I Severina; Natalia V Sumbatyan; Galina A Korshunova; Vadim N Tashlitsky; Vitaly A Roginsky; Yuriy N Antonenko; Maxim V Skulachev; Boris V Chernyak; Vladimir P Skulachev
Journal:  Pharm Res       Date:  2011-06-14       Impact factor: 4.200

6.  EPSA: A Novel Supercritical Fluid Chromatography Technique Enabling the Design of Permeable Cyclic Peptides.

Authors:  Gilles H Goetz; Laurence Philippe; Michael J Shapiro
Journal:  ACS Med Chem Lett       Date:  2014-08-04       Impact factor: 4.345

7.  Interpreting physicochemical experimental data sets.

Authors:  Nicola Colclough; Mark C Wenlock
Journal:  J Comput Aided Mol Des       Date:  2015-06-09       Impact factor: 3.686

8.  A new chemotype with promise against Trypanosoma cruzi.

Authors:  Xiaofang Wang; Monica Cal; Marcel Kaiser; Frederick S Buckner; Galina I Lepesheva; Austin G Sanford; Alexander I Wallick; Paul H Davis; Jonathan L Vennerstrom
Journal:  Bioorg Med Chem Lett       Date:  2019-10-31       Impact factor: 2.823

9.  Structure-Activity Relationship of Antischistosomal Ozonide Carboxylic Acids.

Authors:  Jianbo Wu; Xiaofang Wang; Francis C K Chiu; Cécile Häberli; David M Shackleford; Eileen Ryan; Sriraghavan Kamaraj; Vivek J Bulbule; Alexander I Wallick; Yuxiang Dong; Karen L White; Paul H Davis; Susan A Charman; Jennifer Keiser; Jonathan L Vennerstrom
Journal:  J Med Chem       Date:  2020-03-19       Impact factor: 7.446

10.  QSAR analysis of the inhibition of recombinant CYP 3A4 activity by structurally diverse compounds using a genetic algorithm-combined partial least squares method.

Authors:  Suchada Wanchana; Fumiyoshi Yamashita; Mitsuru Hashida
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.